{"url_path":"/sec/chnr/10-k/2026/item-9","section_key":"item-9","section_title":"Item 9 **","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/793628/0001553350-26-000083-index.html","accession_number":"0001553350-26-000083","cik":"0000793628","ticker":"CHNR","issuer_name":"CHINA NATURAL RESOURCES INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/793628/0001553350-26-000083-index.html","primary_entity_key":"0000793628","primary_entity_name":"CHINA NATURAL RESOURCES INC"},"word_count":675,"has_tables":true,"body_markdown":"**ITEM 9.**\n**THE OFFER AND LISTING**\n\n \n\n \n**A.**\n**Offer and Listing Details**\n\n \n\nThe principal United States\nmarket for our common shares, our only class of outstanding equity securities, is the Nasdaq Capital Market. Our common shares are traded\non the Nasdaq Capital Market under the symbol “CHNR.” We are not aware of any principal market for any of our securities outside\nof the United States. There is no established trading market for the Warrants and we do not intend to list the Warrants on any exchange\nor other trading system.\n\n \n\n \n**B.**\n**Plan of Distribution**\n\n \n\nNot applicable. \n\n \n\n \n**C.**\n**Markets**\n\n \n\nOur common shares have been\nlisted on the Nasdaq Capital Market since November 22, 2004, under the symbol “CHNR.” From August 7, 1995, until\nNovember 22, 2004, our common shares were listed on the Nasdaq SmallCap Market under the symbol “CHRB.”\n\n \n\nAs previously announced, we\nreceived a notification letter from Nasdaq on April 27, 2022, advising the Company that we were not in compliance with the minimum bid\nprice requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq. Nasdaq Listing Rule 5550(a)(2) requires\nlisted securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to\nmeet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. The notification\nletter provided that the Company had 180 calendar days, or until October 24, 2022, to regain compliance with Nasdaq Listing Rule 5550(a)(2).\nTo regain compliance, the Company’s common shares must have a closing bid price of at least $1.00 per share for a minimum of 10\nconsecutive business days.\n\n \n\nOn October 25, 2022, we received\na second notice letter from Nasdaq, in which Nasdaq granted us an additional 180 days, or until April 24, 2023, to regain compliance,\nbecause the Company met the continued listing requirement for market value of publicly held shares and all other applicable requirements,\nexcept the bid price requirement.\n\n \n\n \n\n66 \n\n \n\n \n\nOn April 3, 2023, we effected\na five-to-one share combination of issued and outstanding shares, which was intended to increase the per share trading price of the Company’s\ncommon shares to satisfy the $1.00 minimum bid price required for continued listing on Nasdaq.\n\n \n\nOn April 18, 2023, we received\na notice letter from Nasdaq confirming that the Company had regained compliance with Nasdaq Listing Rule 5550(a)(2).\n\n \n\nOn July 5, 2024, we received\na deficiency letter from the Listing Qualifications Department (the “Staff”) of Nasdaq notifying the Company that, for the\npreceding 30 consecutive business days, the closing bid price for the Company’s Common Shares was below the minimum $1.00 per share\nrequirement for continued listing on Nasdaq pursuant to Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq rules, the Company was\nprovided an initial period of 180 calendar days, or until January 2, 2025, to regain compliance with Nasdaq Listing Rule 5550(a)(2). The\nCompany was unable to regain compliance with Nasdaq Listing Rule 5550(a)(2) by January 2, 2025.\n\n \n\nOn January 3, 2025, Nasdaq\ngranted the Company an additional 180 calendar days, or until June 30, 2025, to regain compliance with Nasdaq Listing Rule 5550(a)(2).\nNasdaq's determination to grant the second compliance period was based on the Company meeting the continued listing requirement for market\nvalue of publicly held shares and all other applicable requirements for initial listing on Nasdaq, with the exception of Nasdaq Listing\nRule 5550(a)(2), and the Company's written notice of its intention to cure the deficiency during the second compliance period by effecting\na reverse stock split, if necessary.\n\n \n\nOn June 13, 2025, we effected\nan eight-to-one share combination of issued and outstanding shares, which was intended to increase the per share trading price of the Company’s\ncommon shares to satisfy the $1.00 minimum bid price required for continued listing on Nasdaq.\n\n \n\nOn June 30, 2025, we received\na notice letter from Nasdaq confirming that the Company had regained compliance with Nasdaq Listing Rule 5550(a)(2).\n\n \n\n \n**D.**\n**Selling Shareholders**\n\n \n\nNot applicable.\n\n \n\n \n**E.**\n**Dilution**\n\n \n\nNot applicable.\n\n \n\n \n**F.**\n**Expenses of the Issue**\n\n \n\nNot applicable."}